1Crowd: One face, many pockets
The Hindu Business Line explores the multiple facets of 1Crowd and how we are reinventing the ways of investing in early stage start-ups. Read more on this link: https://goo.gl/1WbKwx
The Hindu Business Line explores the multiple facets of 1Crowd and how we are reinventing the ways of investing in early stage start-ups. Read more on this link: https://goo.gl/1WbKwx
1Crowd hosted a webinar on “Angel Investing Demystified” on 28th of April 2017. To listen to the insights of our panelists on the topic, you can access the recording using the following link: Webinar Recording
Startup founders know that after family, friends, and other fools, if they need to raise more funds in order to grow, they will need to go to angel investors. A big problem is that there are a lot of misunderstandings about angel investors. Part of this is because their impressions are based on what happens… Read More Raising money from Angel Investors in India
The need to make quality and affordable healthcare accessible to the billion plus population of India has spawned a new breed of healthcare start-ups in the country. According to a joint study by FICCI and KPMG on inside look into funding in Indian healthcare start-ups, six to eight percent of investments in business to consumer… Read More Healthcare Startups – The way forward
There’s a lot of excitement when a start-up is launched, but there’s considerable unhappiness and sorrow when it fails. There’s often a lot of soul searching and recrimination as to why it failed. What went wrong? Who was to blame? What could have been done to salvage it? This is especially true when the startup… Read More Why start-ups need to die
The current scenario regarding low cost healthcare availability in India is pretty bleak. Although globally there has been tremendous growth and progress in the quality of healthcare along with devices and appropriate drugs available to address almost any ailment, accessibility and cost are still huge hurdles in countries like India. With our humungous population, cheap… Read More Impact of novel test & treatment technology on low cost healthcare in India
Prologue: “How did you arrive at that valuation?” That is the commonest question we are asked – by investors and start-ups alike. I’d love to say “like conclusions, it jumped on us!” (but obviously I don’t :). We resort to mumbo jumbo. The raw, stark, blunt, miserable truth is that there exists no known, accepted… Read More Startup Valuations: Like love (and hate!), it’s all in the mind
The startup story is particularly intriguing for one of its characteristics – the fact that it yields morals at frequent intervals, rather than at the very end as in conventional stories. Of course, one may make the argument that it’s a story which is not only unfinished, but also never finished – implying that its… Read More The Startup Story – Well Begun & Not Done